Moderna to increase doses per vial as U.S. COVID-19 vaccination ramps up

  • Moderna (NASDAQ:MRNA) has asked permission from the U.S. FDA to increase the number of doses per vial in its COVID-19 vaccine to 15 from 10, CNBC reported citing a person familiar with the matter.
  • If approved, the change will allow the company to ease the pressure on the fill/finish component in manufacturing.
  • The federal agency approved a similar change to the coronavirus vaccine from Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX), which, according to Pfizer CEO Albert Bourla, would raise the supply by 20%.
  • The rush to ease the supply constraints comes as the U.S. vaccination drive ramps up, with the rolling daily average of shots given standing at ~1. 3M for the week ending Friday, up from ~1.0M in the week before.
  • From ~49.2M doses distributed, ~57% have been administered, compared to nearly 50% in the prior week, and according to the latest CDC data, approximately ~7% of the U.S. population has received at least one dose by Friday compared to ~5% in the week ago.

    Fundamentals Moderna

    For this year the company from Cambridge could earn a total revenue around 518.85 million USD. This is according to the average of the analysts' estimates. This is hugely more than 2019's revenue of 60.21 million USD.

    Historical revenues and results Moderna Inc plus estimates 2020


    The analysts expect for 2020 a net loss of 568 million USD. For this year the consensus of the result per share is a loss of 1.55 USD. The PE-ratio therefore is -101.6.

    For this year analysts don't expect the company to pay a dividend. The average dividend yield of the biotech companies is a low 0.11 percent.

    Based on the current number of outstanding shares Moderna Inc 's market capitalization 51.78 billion USD. The Moderna Inc stock was the past 12 months quite unstable. Since last February the stock is even 673 percent higher. This year the stock price moved between 18 and 186 dollar.

    Historical stock prices Moderna Inc period 2007-2020

    stock analysis modernainc

    Click here for dividend Moderna Inc. At 21.44 the stock trades 0.54 percent higher at 157.48 USD. Nieuwsdienst: +31 084-0032-842

    Copyright B.V.
    All rights reserved. Any redistribution, duplication or archiving prohibited. doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.